Related Experiment Video
Updated: Mar 14, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Intestinal Transplant Inflammation: the Third Inflammatory Bowel Disease
Alexander Kroemer1, Christopher Cosentino2, Jason Kaiser2
1MedStar Georgetown Transplant Institute, 2PHC, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC, 20007, USA. akroemer@me.com.
Intestinal transplantation involves complex immunity. Understanding humoral, innate, and adaptive cellular immunity, including donor-specific antibodies and Th17 cells, is key to improving outcomes for intestinal failure patients.
Area of Science:
- Immunology
- Transplantation Science
- Gastroenterology
Background:
- Intestinal transplantation is a complex procedure with significant immunological challenges.
- Improving outcomes requires a deeper understanding of the immune responses involved.
- Current research focuses on identifying key immune players and their roles.
Purpose of the Study:
- To review recent findings on the immunological aspects of intestinal transplantation.
- To highlight the significance of humoral and cellular immunity in graft survival.
- To discuss novel insights into immune regulation and rejection mechanisms.
Main Methods:
- Literature review of recent studies on intestinal transplantation immunology.
- Analysis of findings related to humoral immunity (donor-specific antibodies).
- Examination of cellular immunity, including innate lymphoid cells and Th17 responses.
Main Results:
- Donor-specific antibodies significantly impact intestinal allograft outcomes.
- NOD2 plays a crucial role in regulating intestinal immunity.
- Innate lymphoid cells demonstrate protective effects.
- Th17 cells are implicated in acute cellular rejection.
Conclusions:
- A comprehensive understanding of immune mechanisms is vital for advancing intestinal transplantation.
- Targeting specific immune pathways may improve graft tolerance and patient survival.
- Further research into immune modulation holds promise for treating intestinal failure.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
08:25A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
Published on: June 10, 2025
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF